You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Rebif®

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Learn About Interferon-beta Exposure of Pregnant Women During

Not yet recruiting
  • Multiple Sclerosis (MS)
  • Avonex (IFNβ-1-a, Biogen Netherlands B.V)
  • +5 more
  • Multiple Locations, Finland
  • +1 more
Sep 19, 2023

Multiple Sclerosis, Relapsing-Remitting Trial in Kocaeli (EK-12, INF beta-1a)

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Kocaeli, Turkey
    Kocaeli University, Faculty of Medicine, Department of Neurology
Jul 23, 2021

Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Non-Hodgkin Lymphoma, Refractory B Acute Lymphoblastic Leukemia Trial

Not yet recruiting
  • Recurrent B Acute Lymphoblastic Leukemia
  • +5 more
  • Interferon Beta-1A
  • +10 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 6, 2023

Assess Adherence to Treatment for Patients With RMS (MAIN-MS)

Completed
  • Relapsing Multiple Sclerosis (RMS)
  • Rebif (Interferon beta-1a)
  • Alger, Algeria
  • +40 more
Mar 22, 2022

Relapsing Multiple Sclerosis Trial (Placebo, BIIB061, Interferon-beta1)

Not yet recruiting
  • Relapsing Multiple Sclerosis
  • Placebo
  • +3 more
  • (no location specified)
Mar 22, 2021

Relapsing Multiple Sclerosis Trial in Worldwide (Interferon beta-1a, Ocrelizumab-matching , Ocrelizumab)

Active, not recruiting
Has Results
  • Relapsing Multiple Sclerosis
  • Interferon beta-1a
  • +3 more
  • Phoenix, Arizona
  • +140 more
Jan 2, 2023

Nasopharyngeal Carcinoma, Nasopharyngeal Cancer, Nasopharyngeal Tumors Trial in Germany (drug, radiation, procedure, behavioral)

Recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • Aachen, Germany
  • +28 more
Aug 24, 2023

Multiple Sclerosis, Relapsing-Remitting Trial in United Kingdom, United States (Early Highly Effective Therapies Group,

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Early Highly Effective Therapies Group
  • Escalation Therapies Group
  • Aurora, Colorado
  • +30 more
Jul 22, 2022

Relapsing Remitting Multiple Sclerosis Trial in Portugal (peginterferon beta-1a, interferon beta-1a, interferon beta-1b)

Completed
  • Relapsing Remitting Multiple Sclerosis
  • peginterferon beta-1a
  • +2 more
  • Amadora, Portugal
  • +14 more
Nov 23, 2020

REbif After Initial Treatment of Multiple Sclerosis (MS)

Terminated
Has Results
  • Multiple Sclerosis
  • Darmstadt, Germany
    Please Contact the Merck KGaA Communication Center
Aug 7, 2018

Interferon Beta Therapy in Participants With Multiple Sclerosis

Completed
  • Multiple Sclerosis, Relapsing-Remitting
  • SC Peginterferon beta-1a
  • +2 more
  • Göttingen, Germany
    Research Site
Sep 24, 2019

Multiple Sclerosis Trial in Worldwide (Cladribine, Placebo, Rebif® new formulation (RNF))

Completed
Has Results
  • Multiple Sclerosis
  • Phoenix, Arizona
  • +157 more
Feb 24, 2021

EPID Multiple Sclerosis Pregnancy Study

Completed
  • Multiple Sclerosis
  • Betaseron (Interferon beta-1b, BAY86-5046), Bayer HealthCare AG
  • +6 more
  • Multiple Locations, Finland
    Many locations
Aug 12, 2019

Multiple Sclerosis, Relapsing-Remitting Trial in Darmstadt (Rebif®)

Completed
Has Results
  • Multiple Sclerosis, Relapsing-Remitting
  • Rebif®
  • Darmstadt, Germany
    Please contact the Merck KGaA Communication Center
Jan 16, 2018

Multiple Sclerosis, Relapsing-Remitting Trial in United States (Early Aggressive Therapy or Traditional Therapy)

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Early Aggressive Therapy or Traditional Therapy
  • Birmingham, Alabama
  • +51 more
Jan 23, 2023

Rebif and Tecfidera on Infections and Lymphocytes

Completed
  • Relapsing-Remitting Multiple Sclerosis
    • Foxboro, Massachusetts
      Neurology Center of New England
    Aug 3, 2018

    Multiple Sclerosis Trial in Naples (IFN beta 1a 44 mcg TIW, Curcumin, Placebo)

    Completed
    Has Results
    • Multiple Sclerosis
    • IFN beta 1a 44 mcg TIW
    • +2 more
    • Naples, Italy
      Investigational Site
    Aug 20, 2018

    Atrial Fibrillation Trial in Genk (Heart rhythm measurements with Preventicus®, Heart rhythm measurements with FibriCheck®,

    Recruiting
    • Atrial Fibrillation
    • Heart rhythm measurements with Preventicus®
    • +3 more
    • Genk, Limburg, Belgium
      Ziekenhuis Oost-Limburg
    Aug 28, 2023

    ECMO Braile Biomédica® in COVID-19 Patients

    Recruiting
    • COVID-19
    • Patients underwent cardiorespiratory support
    • Lago Sul, Brasília - DF, Brazil
      Hospital Brasília
    Oct 13, 2023

    Metastatic Gastric Adenocarcinoma, Second Line, Chemo Trial (nal-IRI /Experimental, Ramucirumab /Experimental,

    Not yet recruiting
    • Metastatic Gastric Adenocarcinoma
    • +2 more
    • nal-IRI /Experimental
    • +2 more
    • (no location specified)
    Jun 25, 2023

    Venous Leg Ulcer, Diabetic Foot Trial in Worldwide (AQUACEL® Ag+ Extra™, Cutimed® Sorbact®)

    Recruiting
    • Venous Leg Ulcer
    • Diabetic Foot
    • AQUACEL® Ag+ Extra™
    • Cutimed® Sorbact®
    • Barranquilla, Colombia
    • +13 more
    May 26, 2023

    Dental Implants Trial in L´hospitalet de Llobregat (Dynamic Computer Assisted Surgery, Freehand)

    Recruiting
    • Dental Implants
    • Dynamic Computer Assisted Surgery
    • Freehand
    • L´hospitalet de Llobregat, Catalunya, Spain
      University of Barcelona
    Aug 31, 2023

    Carpal Tunnel Syndrome Trial in Denizli (KForce Sens, Baseline Electrigoniometer)

    Completed
    • Carpal Tunnel Syndrome
    • KForce Sens
    • Baseline Electrıgoniometer
    • Denizli, Turkey
      Pamukkale University
    Sep 14, 2023

    Tricuspid Regurgitation, Tricuspid Valve Disease Trial in Worldwide (TricValve® Transcatheter Bicaval Valve System, Medical

    Not yet recruiting
    • Tricuspid Regurgitation
    • Tricuspid Valve Disease
    • TricValve® Transcatheter Bicaval Valve System
    • Medical Therapy Arm
    • Cleveland, Ohio
    • +10 more
    Nov 14, 2023

    Vaccine-Preventable Diseases, Typhoid Fever, Cholera Trial in Helsinki (Oral typhoid fever vaccine, Oral cholera vaccine)

    Recruiting
    • Vaccine-Preventable Diseases
    • +2 more
    • Oral typhoid fever vaccine
    • Oral cholera vaccine
    • Helsinki, Finland
      Meilahti Vaccine Research Center, Helsinki University Hospital
    Oct 27, 2023